Rubric Capital Management LP Teva Pharmaceutical Industries LTD Transaction History

Rubric Capital Management LP

$3.59 Billion
Q3 2024

A detailed history of Rubric Capital Management LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Rubric Capital Management LP holds 16,005,498 shares of TEVA stock, worth $364 Million. This represents 8.03% of its overall portfolio holdings.

Number of Shares

16,005,498

Previous 17,261,741 7.28%

Holding current value

$364 Million

Previous $281 Million 2.82%

% of portfolio

8.03%

Previous 8.31%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $19.9 Million - $23.8 Million	-1,256,243 Reduced 7.28%	16,005,498 $288 Million
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $5.21 Million - $7.1 Million	-407,847 Reduced 2.31%	17,261,741 $281 Million
Q1 2024 May 10, 2024	SELL	$10.67 - $14.43 $5.94 Million - $8.04 Million	-557,013 Reduced 3.06%	17,669,588 $249 Million
Q4 2023 Feb 13, 2024	SELL	$8.12 - $10.63 $6.28 Million - $8.22 Million	-773,399 Reduced 4.07%	18,226,601 $190 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $2.11 Million - $3.01 Million	281,638 Added 1.5%	19,000,000 $194 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $102 Million - $135 Million	14,218,556 Added 315.98%	18,718,362 $141 Million
Q1 2023 May 12, 2023	BUY	$8.36 - $11.37 $37.6 Million - $51.2 Million	4,499,806 New	4,499,806 $39.8 Million
Q1 2019 May 10, 2019	SELL	$15.58 - $20.01 $12.9 Million - $16.6 Million	-830,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $12.1 Million - $19.8 Million	830,000 New	830,000 $12.8 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Account

Rubric Capital Management LP Teva Pharmaceutical Industries LTD Transaction History